**Specifications Table**TableSubject areaBiologyMore specific subject areaVascular PharmacologyType of dataGraphHow data was acquiredIsometric force transducer (TRI201; Panlab, Spain)Data formatAnalyzedExperimental factorsThe thoracic aorta was isolated from male Wistar rats or C57BL/6 mice, cut into rings (4 mm in length) and maintained in organ chambersExperimental featuresInhibitors of distinct pathways were used to determine the mechanisms underlying succninate-induced contractionData source locationRibeirao Preto, BrazilData accessibilityData are within this article

**Value of the data**•Succinate displays a direct contractile effect on the vasculature.•The contraction induced by succinate is partially mediated by GPR91 receptors.•The data provide insights into the mechanisms underlying the contractile effect of succinate.

1. Data {#s0005}
=======

Data describes the contractile action of succninate. [Fig. 1](#f0005){ref-type="fig"} shows representative traces of the contractile effect of succinate on endothelium-intact and endothelium-denuded aortic rings from Wistar rats and C57BL/6 or GPR91^−/−^ mice. The maximal contraction induced by succinate in endothelium-intact and endothelium-denuded aortas isolated from Wistar rats and C57BL/6 or GPR91-deficient mice are represented on [Fig. 2](#f0010){ref-type="fig"}.

The effects of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contraction are represented on [Fig. 3](#f0015){ref-type="fig"}. The contractile response induced by succinate on endothelium-intact and endothelium-denuded rat aortic rings was reduced by indomethacin, H7, verapamil and tiron ([Fig. 4](#f0020){ref-type="fig"}).

2. Experimental design, materials and methods {#s0010}
=============================================

Male Wistar rats (230--250 g) and C57BL/6 or GPR91^−/−^ mice (20--25 g) were anaesthetized intraperitoneally with urethane at 1.25 g/kg (Sigma-Aldrich, St. Louis, MO, USA) and the thoracic aorta was mounted in organ chambers [@bib1]. The contraction induced by succinate (50--130 mmol/L) was evaluated in endothelium-intact and endothelium-denuded rat aortic rings. In another set of experiments, the contractile effect of succinate (0.03--130 mmol/L) was evaluated in endothelium-intact and endothelium-denuded aortic rings from C57BL/6 and GPR91^−/−^ mice [@bib2].

In another set of experiments, the contractile response induced by succinate was evaluated in endothelium-intact or endothelium-denuded rat aortic rings incubated for 30 min with one of the following drugs: SB203508 (10 µmol/L, p38MAK inhibitor), SP600125 (10 µmol/L, JNK inhibitor), PD98059 (10 µmol/L, ERK1/2 inhibitor), Y27632 (10 µmol/L, Rho-kinase inhibitor), H7 (10 μmol/L, protein kinase C inhibitor), indomethacin (10 μmol/L, non-selective cyclooxygenase inhibitor), tiron (superoxide anion scavenger, 100 μmol/L) or verapamil (1 μmol/L, Ca^2+^ channel blocker).

Results are expressed as means±standard errors of the mean (S.E.M.). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Newman--Keuls multiple comparison test. *P* values of less than 0.05 were considered significant.
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![Original traces showing the contractile effect of succinate. The contraction induced by succinate was obtained in endothelium-intact (Endo+) and endothelium-denuded (Endo−) aortic rings isolated from Wistar rats and C57BL/6 or GPR91^−/−^ mice.](gr1){#f0005}

![Contractile responses induced by succinate on rat and mouse aortic rings. The contraction induced by succinate was studied on endothelium-intact (Endo+) and endothelium-denuded (Endo−) aortic rings from Wistar rats (A) and C57BL/6 or GPR91^−/−^ mice (B and C). Results are presented as means±S.E.M. of 7 to 9 experiments. \*Compared to C57BL/6;\*\*Compared to Endo+ (*P*\<0.05, ANOVA followed by Newman--Keuls multiple comparison test).](gr2){#f0010}

![Effect of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contractile response in endothelium-intact (left) and endothelium-denuded (right) rat aortic rings. The contractile response induced by succinate was determined before (control) or after incubation for 30 min with SB203508 (10 µmol/L), SP600125 (10 µmol/L), PD98059 (10 µmol/L) or Y27632 (10 µmol/L). Results are presented as means±S.E.M. of 6 to 10 experiments. \*Compared to respective control group (*P*\<0.05, ANOVA followed by Newman--Keuls multiple comparison test).](gr3){#f0015}

![Effect of indomethacin, H7, tiron and verapamil on succinate-induced contractile response in endothelium-intact and denuded rat aortic rings. The contractile response induced by succinate was determined before (control) or after incubation for 30 min with indomethacin (10 µmol/L), H7 (10 µmol/L), verapamil (1 µmol/L) or tiron (100 µmol/L). Results are presented as means±S.E.M. of 6 to 10 experiments. \*Compared to respective control group (*P*\<0.05, ANOVA followed by Newman--Keuls multiple comparison test).](gr4){#f0020}
